Medical Malpractice Payments Have Fallen for Eighth Year: Report

|||

A new report by the consumer watchdog group Public Citizen indicates that medical malpractice payments dropped to an all-time low last year, despite claims by tort reform proponents that medical malpractice lawsuits are a driving force behind the increasing cost of health care. 

The new report on medical malpractice payments (PDF) was released on July 11, finding that both the number of malpractice payments and their value were the lowest they have been since 1991, the earliest year such numbers were tracked.

The report also found that litigation reform measures, such as overriding jury decisions on damage awards with arbitrary legislative caps on payments, did nothing to bring down healthcare costs or protect patients.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

Researchers found that in actuality, so-called tort reform measures likely increased healthcare costs by passing on the price of uncompensated medical errors to taxpayers, instead of having those responsible pay the proper compensation for injuries and disability they caused.

According to data from the National Practitioner Data Bank, the overall value of all medical malpractice payments made in 2011 accounted for only 0.12 percent of the nation’s healthcare costs. That is just slightly more than one-tenth of one penny for every dollar spent. The payments fell for the eighth straight year, despite some claims that medical malpractice costs were on the rise.

Some proponents of medical malpractice reform have suggested that most claims are frivolous, but Public Citizen’s analysis determined that 80% of claims that actually resulted in payments were the result of cases where patients suffered death, catastrophic harm or serious permanent injury.

Despite the reality of falling medical malpractice costs, the health care industry failed to pass those savings on to customers, the report found. From 2000 to 2011, the cost of health care in the United States has increased about 97%. During the same time period, the value of medical malpractice payments dropped about 12%.

The report highlights the impact of medical malpractice reforms introduced in Texas in 2003, which included a $250,000 cap on non-economic damages. Despite malpractice payments by doctors dropping 65% since the cap was put in place, health care insurers have been raising premiums on Texas physicians faster than the national average.

The reforms were sold to Texans as a means of making healthcare more affordable and accessible, but the only apparent result has been an inability of Texans to be compensated for the full value of medical malpractice-based injuries, and higher health care costs.

Last month, the Journal of Empirical Legal Studies issued a study supporting Public Citizen’s conclusions on Texas health care costs. The report concluded that the “accumulation of recent evidence finding zero or small effects suggests that it is time for policymakers to abandon the hope that tort reform can be a major element in health-care cost control.”

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.

Image Credit: |||



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Cartiva is urging federal judges to reject consolidation of toe-implant lawsuits, arguing that an MDL would interfere with individual claim resolutions that the company says are already being handled efficiently outside of court.
The first Covidien Symbotex mesh bellwether has been restored to the 2026 trial calendar, signaling renewed momentum in a litigation where more than 2,000 similar claims are still awaiting resolution.
In the first federal trial over claims of Uber driver sexual assaults, a lawsuit involving the rape of a passenger will go before a jury on January 13.